Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №9 (2025) > Critical issues in the radiotherapy of cervix utery cancer

Critical issues in the radiotherapy of cervix utery cancer

Islim (Salim) Nidal , Alexander V. Stolbovoy , Serghey A. Ryzhkin

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Radiotherapy (RT) of the cervical cancer (CC), as distinct from RT of almost all cancers, has essential feature. That is the irradiation consists of two methodically different phases – external beam radiotherapy (EBRT) and intracavitary/interstitial brachytherapy (BT). Nowadays we see the great progress in both methodologies and results of the treatment of majority cancers during last 10–15 years sizable improved. On this background we should to assume the right to expect the consistent improvement of the results of treatment of CC, but it doesn’t take place. Consequently, there is the question, if the cause of failure is contained in the essential feature of RT? We have done the analysis of the problem in the aim to get the way to improve the treatment of CC and revealed the most critical peculiarities in the second phase of RT of CC. on the base of our analysis we presume measures to rise survival. Our historical analysis reveals, that we have exhaustive theoretical elaborations for BT of CC, but its practical implementation constrains in real life of hospitals. The effectiveness of contemporary methods of RT proved and for improvement of results of the treatment of CC it is need to find the changes at first in the second phase of the irradiation and in increase of investment of EBRT. Probably, (it must be investigated undelayable), EBRT needs to rich 60–66 Gy, though in affected parametrium, keeping in mind that BT-boost will work in some centimeters from the source. It is very cumbersome in adaptive RT to perform multiple dosimetric replanning and on-line IGRT, to sum dosimetry from two phases, and EBRT+BT itself is more difficult than usual RT. We ought to consider expenditure of advanced methods of the treatment and do not make them financially toxic for the patients.
Keywords: Cervix uteri, combined radiotherapy, brachytherapy, standards of treatment, critical issues, survival.

About the Author

Islim (Salim) Nidal 1 2 , Alexander V. Stolbovoy 1 2 , Serghey A. Ryzhkin 2 3

1 European Medical Center, Moscow, Russia

2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

3 Kazan State Medical University, Kazan, Russia

References

1. Podwika SE, Duska LR. Top advances of the year: Cervical cancer. Cancer 2023;129(5):657-63. DOI: 10.1002/cncr.34617 
2. Jemal A, Ward EM, Johnson CJ et al. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst 2017;109(9):djx030. DOI: 10.1093/jnci/djx030 
3. Злокачественные новообразования в России в 2022 г. (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой, И.В. Лисичниковой. М., 2023. Malignant neoplasms in Russia in 2022 (morbidity and mortality). Edited by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova, I.V. Lisichnikova. Moscow, 2023 (in Russian). 
4. Yadav G, Srinivasan G, Jain A. Cervical cancer: Novel treatment strategies offer renewed optimism. Pathol Res Pract 2024;254:155136. DOI: 10.1016/j.prp.2024.155136 
5. Margaret Cleaves. In Wikipedia, The Free Encyclopedia. Retrieved 03:57, February 17, 2022. URL: https: en. wikipedia.org/w/index.php?title=Margaret_Cleaves&oldid=1046674626 
6. Cleaves M. Radium: With a preliminary note on Radium rays in the treatment of cancer. Medical Record 1903;64(16):601-6. 
7. Tod M, Meredith W. A dosage system for use in the treatment of cancer of uterine cervix Brit J Radiol 1938;11(132):809-24. 
8. Blomfield G. The treatment of cancer of the uterine cervix by radium and x-ray therapy. Brit J Radiol 1961;34(408):755-68. 
9. Murphy W. Radiation therapy. 2nd ed. W.B. Saunders company: Philadelphia, London, 1967. P. 618. 
10. ICRU Report No. 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: ICRU; 1978. 
11. ICRU Report No. 62. Prescribing, recording, and reporting photon beam therapy, Supplement to ICRU Report No.50. ICRU Report 62. Bethesda, MD: ICRU; 1999. 
12. ICRU Report No. 38. International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU Report 38, Bethesda, MD; 1985. 
13. ICRU Report No. 89. Prescribing, recording, and reporting brachytherapy for cancer of the cervix. Journal of the ICRU. 2013;13(1-2):274. 
14. ICRU Report No. 71. Prescribing, recording, and reporting electron beam therapy. Journal of the ICRU 2004;4(1). 
15. ICRU Report No. 83. Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). ICRU Report 83. Journal of the ICRU 2010;10(1). 
16. Viswanathan A, Creutzberg C, Craighead P et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012;82(1):250-5. DOI: 10.1016/j.ijrobp.2010.10.030 
17. Рак шейки матки. Клинические рекомендации Минздрава России. М., 2020. ID: 537. URL: https: cr.minzdrav.gov.ru/recomend/537_1 (дата обращения 02.04.2025). Cervical cancer. Clinical recommendations of the Ministry of Health of Russia. Moscow, 2020. ID: 537. URL: https: cr.minzdrav.gov.ru/recomend/537_1 (accessed 04/02/2025). (in Russian). 18. National Comprehensive Cancer Network (NCCN) Guidelines v.3.2025 NCCN Guidelines Version 3.2024 Cervical Cancer. URL: https: www.nccn.org/professionals/physician_gls/pdf/cervical.pdf (accessed 12/12/2024). 
19. Lavrova E, Garrett MD, Wang YF et al. Adaptive Radiation Therapy: A Review of CT-based Techniques. Radiol Imaging Cancer 2023;5(4):e230011. DOI: 10.1148/rycan.230011 
20. van de Schoot AJ, Hoffmans D, van Ingen KM et al. Characterization of Ethos therapy systems for adaptive radiation therapy: A multi-machine comparison. J Appl Clin Med Phys 2023;24(5):e13905. DOI: 10.1002/acm2.13905 
21. Zhang Y, Wang G, Chang Y et al. Prospects for daily online adaptive radiotherapy for cervical cancer: Auto-contouring evaluation and dosimetric outcomes. Radiat Oncol 2024;19(6). DOI: 10.1186/s13014-024-02398-6 
22. Withers H. Biologic basis of radiation therapy. In: Perez C., Brady L. (Eds.) Principles and practice of radiation oncology. 2nd ed. Philadelphia: J.B. Lippincott Co.1992. P. 64–96. 
23. Lee S, Leu M, Smathers J et al. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys1995;33(2):375-89. 
24. Yarnold J, Haviland J. Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy. The Breast 2010;19(3):176-9. 
25. Yarnold J, Bentzen S, Coles C, Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011;79(1):1-9. DOI: 10.1016/j.ijrobp.2010.08.035 
26. Bentzen S, Joiner M. The linear-quadratic approach in clinical practice. In: Joiner M. and van der Kogel A. (Eds.) Basic clinical radiobiology. 5th ed. CRC Press, Boca Raton, 2019. P. 116. 
27. Bentzen S. Radiation dose-response relationships. In: Joiner M and van der Kogel A (Eds.). Basic clinical radiobiology. 5th ed. CRC Press, Boca Raton, 2019. P. 49. 
28. Lindengaard J, Pötter R, van Limbergen E, Haie-Meder. Clinical aspects of threatment planning. In: Viswanathan A, Kiristis C, Erickson B, Pötter R (Eds.). Gynecologic radiation therapy: Novel approaches to image-guidance and managment. Springer, Heidellberg, 2011. P.119–30. 
29. Viswanathan A, Cormack R, Rawal B, Lee H. Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer. Int J Gynecol Cancer 2009;19(8):1402-6. DOI: 10.1111/IGC.0b013e3181b62e73 
30. Kuipers T, Hoekstra C, van Riet A et al. HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: modified principles of treatment. Radiother Oncol 2001;58(1):25-30. DOI: 10.1016/s0167-8140(00)00320-0 
31. Kirisits C, Lang S, Dimopoulos J et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65(2):624-30. DOI: 10.1016/ j.ijrobp.2006.01.036 32. Locks SM. Dose and volume specification for reporting interstitial therapy (ICRU report 58). The International Commission on Radiation Units and Measurements, ICRU, Bethesda, 1998. 
33. Alieva M, van Rheenen J, Broekman M. Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis 2018;35(4):319-31. DOI: 10.1007/s10585-018-9896-8 
34. Barraclough L. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiation Oncology Biol Phys 2008;71(3):772-8. DOI: 10.1016/j.ijrobp.2007.10.066 
35. Landoni F, Maneo A, Colombo A et al. Randomised stady of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40. 
36. Cengiz M, Gurdalli S, Genc M et al. Comment on «Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and histopathologic finding in 33 patients with operable cervix carcinoma». Radiotherapy and oncology 2005;75(3):367-8. 
37. Cengiz M, Gurdalli S, Selek U et al. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: tree-dimentional computed tomography plan evaluation. Int J Rad Oncol Boil Phys 2008;70(2):464-8. 
38. Fletcher G. Textbook of radiotherapy. Lea & Febiger: Philadelphia, 1966. P. 434–474. 
39. Garcia M. Host factors affecting the radiation response in carcinoma of the cervix Proceedings of the conference on research on the radiotherapy of cancer. American cancer Society, 1961. Р. 133. 
40. DeLuca PJr, Kiristis C, Pˆtter R. In: Prescribing, recording, and reporting brachytherapy for cancer of the cervix. ICRU Report No. 89. Journal of the ICRU 2013;13(1):2. 
41. Kim H, Lee Y, Benedict S et al. Dose Summation Strategies for External Beam Radiation Therapy and Brachytherapy in Gynecologic Malignancy: A Review from the NRG Oncology and NCTN Medical Physics Subcommittees. Int J Radiat Oncol Biol Phys 2021;111(2):999-1010. DOI: 10.1016/j.ijrobp.2021.06.019 
42. Assenholt M, Petersen J, Nielsen S et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47(7):1337-43. DOI: 10.1080/02841860802266698 
43. Georg D, Kirisits C, Hillbrand M et al. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008;71(4):1272-8. DOI: 10.1016/j.ijrobp.2008.03.032 
44. Ferreira P, Braga-Filho A, Barletta A, Ilha L. Radiation therapy alone in stage III-B cancer of the uterine cervix--a 17-year old experience in southern Brazil. Int J Radiat Oncol Biol Phys 1999;45(2):441-6. DOI: 10.1016/s0360-3016(99)00178-9 
45. Yahya S, Bhatt L, King M et al. Survival and Toxicity Following Chemoradiation for Carcinoma of the Cervix – Impact of Multiple-phase Treatment and Shielding. Anticancer Res 2015;35(10):5567-74. PMID: 26408727.
46. Humphrey P, Dures E, Hoskin P, Cramp F. Brachytherapy for locally advanced cervical cancer: A survey of UK provision of care and support. Radiother Oncol 2021;159:60-6. DOI: 10.1016/j.radonc.2021.03.007 
47. Serban M, Kirisits C, Pˆtter R et al. EMBRACE Collaborative Group. Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy. Radiother Oncol 2018;129(3):567-74. DOI: 10.1016/j.radonc.2018.09.002 
48. Nagao A, Okamoto H, Nakayama H et al. Assessment of intrafractional motion of the cervix-uterus by MR-guided radiotherapy system. J Radiat Res 2023;64(6):967-72. DOI: 10.1093/jrr/rrad072. PMID: 37816679 
49. Sagae S, Toita T, Matsuura M et al. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. Int J Gynecol Cancer 2023;33(8):1295-303. DOI: 10.1136/ijgc-2022-004230 
50. Girda E, Randall LM, Chino F et al. Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement. Gynecol Oncol 2023;179:115-22. DOI: 10.1016/j.ygyno.2023.10.017 
51. Salim N, Tumanova K, Stolbovoy A et al. Adaptive VMAT Radiotherapy to Avoid Brachytherapy in Cervical Cancer Treatment. Int J Radiat Oncol Biol Phys 2022;114(3):e262. 
52. Столбовой А.В., Ислим Н., Лойко И.Е. и др. Проблемы в лечении рака шейки матки. Клинический разбор в общей медицине. 2024;5(7):12-6. Stolbovoy A.V., Islim N., Loiko I.E. et al. Issues in the treatment of cervix uteri. Clinical review for general practice. 2024;5(7):12-6 (in Russian). 
53. Собина С.С., Столбовой А.В., Каганов О.И. и др. Исследование факторов, оказывающих влияние на успех лучевого лечения рака шейки матки. В кн.: Материалы XXVIII Российского онкологического Конгресса. М., 2024. Sobina S.S., Stolbovoy A.V., Kaganov O.I. et al. Investigation of factors influencing the success of radiation treatment of cervical cancer. In: Proceedings of the XXVIII Russian Cancer Congress. Moscow, 2024 (in Russian). 
54. Титова В.А. Рак шейки матки: реалистичный подход к эволюционному развитию лучевой терапии, интеллектуальные и технические возможности. Взгляд эксперта. Вестник Российского научного центра рентгенорадиологии. 2022;22(4):361-72. Titova V.A. Cervical cancer: a realistic approach to the evolutionary development of radiation therapy, intellectual and technical capabilities. An expert's view. Bulletin of the Russian Scientific Center of X-ray Radiology. 2022;22(4):361-72 (in Russian). 
55. Солодкий В.А., Титова В.А., Паньшин Г.А. Эволюционное развитие технологий лучевой терапии местнораспространенного рака шейки матки. Вопросы онкологии. 2023;69(1):15-23. DOI 10.37469/0507-3758-2023-69-1-15-23 Solodkiy V.A., Titova V.A., Panshin G.A. The evolutionary development of radiation therapy technologies for locally advanced cervical cancer. Issues of oncology. 2023;69(1):15-23. DOI 10.37469/0507-3758-2023-69-1-15-23 (in Russian). 
56. Солодкий В.А., Титова В.А., Паньшин Г.А. Современная конформная лучевая терапия при противоопухолевом лечении местнораспространенного рака шейки матки. Вопросы онкологии. 2023;69(5):824-34. DOI: 10.37469/0507-3758-2023-69-5-824-834 Solodkiy V.A., Titova V.A., Panshin G.A. Modern conformal radiation therapy in the antitumor treatment of locally advanced cervical cancer. Issues of oncology. 2023;69(5):824-34. DOI: 10.37469/0507-3758-2023-69-5-824-834 (in Russian). 
57. Паньшин Г.А., Титова В.А. Возможно ли и нужно ли не применять брахитерапию при радиотерапевтическом лечении больных местнораспространенным раком шейки матки? Вопросы онкологии. 2024;70(3):557-63. DOI: 10.37469/0507-3758-2024-70-3-557-563 Panshin G.A., Titova V.A. Is it possible and necessary not to use brachytherapy in radiotherapeutic treatment of patients with locally advanced cervical cancer? Issues of oncology. 2024;70(3):557-63. DOI: 10.37469/0507-3758-2024-70-3-557-563 (in Russian).

For citation:Islim (Salim) N., Stolbovoy A.V., Ryzhkin S.A. Critical issues in the radiotherapy of cervix utery cancer. Clinical review for general practice. 2025; 6 (9): 89–94 (In Russ.). DOI: 10.47407/kr2025.6.9.00678


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru